Abstract
Revolutionizing cancer treatment and improving patient outcomes could be achieved through the development of smart drug delivery strategies for Vitamin D3 in cancer cells. Smart drug delivery strategies are crucial in administering Vitamin D3 to cancer cells with high specificity, efficacy, and minimal side effects. One unconventional method for smart drug delivery of Vitamin D3 in cancer cells is gene therapy - a cutting-edge technology that could alter the course of cancer treatment. Vitamin D3 is renowned for its anti-cancer properties, and its targeted delivery to cancer cells is paramount for successful treatment. In conclusion, smart drug delivery strategies have demonstrated significant potential in transporting Vitamin D3 to cancer cells with high specificity, efficacy, and minimal side effects. Nanocarriers such as liposomes, nanoparticles, and dendrimers possess unique characteristics that make them ideal for Vitamin D3 delivery. These carriers can precisely target cancer cells, discharge Vitamin D3 solely in the cancerous environment, and reduce the harmful effects on healthy cells. Gene therapy is a potential alternative to conventional drug delivery methods, paving the way for a brighter future in cancer treatment.